Rat intestinal fatty acid binding protein (I-FABP) is a member of a family of cytoplasmic hydrophobic ligand-binding proteins. To gain insights about the contribution of bound fatty acid to I-FABP's conformation and mechanism of ligand binding, we have determined the structure of Escherichia coli-derived rat apo-I-FABP to 1.96-A resolution and compared it to the recently refined structure of I-FABP with bound palmitate. Both apo-and holo-I-FABP are composed primarily of anti-parallel (3-strands which form two nearly orthogonal (-sheets ("(3-clam"). The overall structures of the apo-and holo-I-FABP are nearly identical, with a root mean square (rms) difference of 0.37 A between C' atoms, 0.38 A between all main-chain atoms, and 0.94 A between all side-chain atoms. However, rms differences of greater than 1.3 A were noted for the side chains of Ile-23, Lys-27, Arg-56, Leu-72, Ala-73, and Asp-74. The space occupied by bound ligand in the core of the holoprotein is occupied in the apoprotein by ordered solvent molecules. This results in an increase in the total number of internal ordered solvent molecules from 7 in the holoprotein to 13 in apo-I-FABP. This finding, together with observed differences in the side-chain orientations of two residues (Arg-56 and Lys-27) situated over a potential opening to the cores of the apo-and holoproteins, suggests that solvent molecules play a critical role in ligand binding. Moreover, the data indicate that the (3-clam structure is stable even in the absence of bound ligand.
Rat intestinal fatty acid binding protein (I-FABP) is a 15-kDa protein which binds one molecule of long-chain saturated or unsaturated fatty acid in a noncovalent manner with Kd values of 1-4 ,uM (1) . Although the precise function of this cytoplasmic protein is not known, it is believed to participate in the uptake, intracellular targeting, and/or metabolic processing of fatty acids within the intestinal epithelial cell population (2) . In addition, I-FABP may protect other proteins and membranes from the deleterious effects of high concentrations of fatty acids.
I-FABP is a member of a family of cytoplasmic hydrophobic ligand-binding proteins that contains 10 known members (summarized in refs. [3] [4] [5] . The tertiary structures of I-FABP (6, 7) and the homologous P2 protein of peripheral nerve myelin (3) have recently been determined with bound fatty acid. Both holoproteins consist of two nearly orthogonal /3-sheets formed by 10 antiparallel /3-strands. This structure resembles a clam shell and has been called a "/3-clam" (6) .
The C' structures of I-FABP and P2 with bound ligand are remarkably similar (3, 7) with a calculated root-mean-square (rms) difference ofless than 1.8 A. The overall conformations of I-FABP and P2 resemble those of a group of extracellular hydrophobic ligand-binding proteins. This group includes serum retinol-binding protein (8) , bilin-binding protein/ insecticyanin (9) (10) (11) , /-lactoglobulin (12) (13) (14) , and several other sequences. All ofthese extracellular proteins have eight antiparallel 83-strands forming a /3-barrel that is open to the exterior at one end. The ligand-binding sites have been defined for several members of this superfamily of intra-and extracellular proteins (3, (7) (8) (9) (10) (11) (12) (13) (14) . All of these proteins have their bound ligands located within their cores. For P2 (3) and I-FABP (7), the fatty acids occupy a significant volume ofthis interior cavity. The interactions that occur between many of the internal amino acid side chains and the bound fatty acid appear to be important for maintaining the conformation of the ligand and possibly the protein itself. However, direct exploration of the latter notion has been "limited" to the use of molecular dynamic simulations. For example, Aqvist et al. (15) have used the coordinates of serum retinol-binding holoprotein to predict the tertiary structure of the corresponding apoprotein.
To directly examine the role of ligand in maintaining the conformation of a representative /-clam protein, we have determined the tertiary structure of apo-I-FABP at 1.96-A resolution. A comparison of the refined structures of the apoprotein and the holoprotein (containing bound palmitate) indicates that the overall conformation of I-FABP does not change upon removal of ligand. Nonetheless, very distinct movements of several side chains located near a potential opening to the protein's core have been identified. Six more ordered solvent molecules were observed within the apoprotein's cavity in addition to the seven already present in the holoprotein. One of these appears to occupy a position within the apoprotein which is analogous to that of the carboxylate group of the bound palmitate present in holo-I-FABP. A hypothesis is presented that links solvent to ligand binding in this, and potentially other, hydrophobic ligand-binding proteins.
MATERIALS AND METHODS
Preparation of Crystalline Delipidated Rat I-FABP from Escherichia coli. Rat I-FABP was expressed and purified from E. coli (1, 7). The protein was then delipidated by passage through hydroxyalkoxypropyldextran (Lipidex 1000, Sigma), using a previously described protocol (1) . The extent of delipidation was judged to be greater than 98% on the basis of a [14C]palmitate-binding assay (1) . Crystals of apo-I-FABP were produced by free interface diffusion (16) under conditions identical to those used to crystallize palmitatecomplexed, E. coli-derived rat I-FABP (6, 7); i.e., the final solution contained I-FABP (20 mg/ml) piperazine-N,N'-bis(2-ethanesulfonic acid) ( 
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The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact. X-ray diffraction data for crystalline apo-I-FABP were collected on a CAD4 diffractometer. Six crystals produced in a single vial were used for all of the data collection. Single I-FABP crystals were used to obtain data in shells of resolution. Each shell of data was overlapped with other resolution-range shells to allow for the collection of common reflections for scaling purposes. Lorentz-polarization and absorption corrections were done as described (7) . Diffraction data were processed, scaled, and merged with the ROCKS x-ray crystallographic program package (17) , yielding an R-merge on intensity of 14% for the complete data set. This relatively high R factor is probably due to errors for the reflections with low net intensities, including many of the high-resolution reflections. Specifically, the R factor for merging data between 10 A and 2.5 A was 8.2%, while the R factor for data between 2.5 A and 2 A was 16.2%.
X-Ray Phasing Method. The tertiary structure of crystalline apo-I-FABP was solved by using the molecular replacement method incorporated into the program package MERLOT (18) . The refined model of palmitate-complexed I-FABP (7), without solvent and fatty acid, was used as a probe to solve the Crowther fast rotation function (CROSUM) as well as the translation function (TRANSUM) for the apoprotein. These results are presented in Table 1 .
The values of a, /3, and y in the solution of the rotation function suggested that it was possible to reindex the apo-I-FABP data in the reciprocal lattice of holo-I-FABP. The transformation matrix used for this reindexing was change in the unit cell dimensions and a 4.9°change in the /3 angle. The R factor between the reindexed apo-I-FABP and the holo-I-FABP data from 15 A to 3 A was 32% (versus 56% for the mismatched indexing). The initial indexing scheme was used for the apo-I-FABP data.
Refinement of Apo-I-FABP to 1.96-A Resolution. Energy refinement and molecular dynamics (19) , least-squares refinement (20) , and molecular model building were used to complete the high-resolution tertiary structure of apo-I-FABP. The refinement results are presented in Table 2 . The results of the molecular replacement were applied to the model of holo-I-FABP, without solvent or fatty acid. This model was first refined with structure-factor-restrained energy refinement and molecular dynamics simulation by using XPLOR (19) . The IFol > 1.5 oC) were next used for structure factor restrained energy refinement and molecular dynamics simulation. This was performed in the same manner as the first phase of XPLOR described above, with the inclusion of higher-resolution data (see Table 2 ). us to refine the model to the geometry shown in Table 2 and to finalize the positions of the 62 ordered solvent molecules.
To verify the positions assigned to ordered solvent in the final model of apo-I-FABP, a macrocycle of TNT was run while using the final coordinates without solvent. The result- A2. In addition, there were no assigned solvent atoms with very low temperature factors (i.e., 1-3 A2), indicating that the solvent atom in question was possibly an ion.
Holo-and Apo-I-FABP Have Similar Overall Structures. We have recently determined the high-resolution tertiary structure of I-FABP containing bound palmitate (7). The protein contains 10 antiparallel P-strands (named /3A-,3J) arranged in two nearly orthogonal p-sheets (Fig. 1) . Two a-helices are located between 83A and BB. Helix I appears as a continuation of the first p-strand (A) and is connected to helix II via a sharp turn. Helix II is continuous with strand BB.
Holo-I-FABP has a relatively large surface area containing many charged side chains. A 9-A "gap" is present between the CG chains of SD and 83E (residues 55-73 in Fig. 1 ). In the holoprotein, this "gap" is bridged by the side chains of amino acids contained in these two strands and by ordered solvent molecules (7). Fifty-three bound solvent molecules were identified on the surface of the holoprotein, forming a fairly uniform solvent surface. A solvent-accessible opening ("portal") to the core of the protein is formed by the tight turns which occur between p-strands C and D, E and F, and helix aII (residues 24-33 in Fig. 1 ). This area was thought to be a potential entry and/or exit site for the fatty acid (7).
The overall structure of apo-I-FABP is nearly identical to that of the palmitate-containing protein described above (see Figs. 1 and 3) . Superimposition of the two structures yields a calculated rms deviation of0.37 A for CG atoms (Fig. 1), 0.38 A for all main-chain atoms, and 0.94 A for all side-chain atoms. Like that of the holoprotein, the surface of apo-I-FABP is made up ofthe side chains of many ionizable amino acids (Fig. 2) and bound solvent molecules. We have refined the positions of 62 ordered solvent molecules in the apoprotein. Thirty-five ofthese solvent molecules are located within 2.0 A of the positions occupied by solvent molecules in the superimposed holoprotein. There are no gross conformational differences in the main chains ofthe two proteins which could result in a large change in the surface charge. This was confirmed by superimposition of the two models, in which no obvious variation in the surface charge distribution could be Proc. Natl. Acad. Sci. USA 86 (1989) detected, although close inspection of the two structures did reveal a number of minor differences in the orientations of exterior side chains.
Differences Between the Structures of Holo-and Apo-I-FABP. The largest variation between the Ca positions of the two models occurs in the first three NH2-terminal residues (Fig. 1 ). These differences may be attributable to flexibility normally found for NH2-terminal regions of proteins. There are also a number of side-chain differences, which are principally located within the so-called portal region of the proteins. Of particular interest is the position of the side chains of Arg-56 and Lys-27 (see Fig. 3 Upper). In the holoprotein, the guanidinium group of Arg-56 points towards 3-strand E, leaving one of its amino groups oriented towards the exterior and the other towards the interior of the protein.
The exteriorly oriented amino group is hydrogen bonded to an ordered solvent molecule and the other amino group is part of an internal "electrostatic network" including two solvent molecules, Tyr-70, and Glu-51. By contrast, the entire guanidinium group of Arg-56 is tucked into the interior of apo-I-FABP, forming a number of hydrogen bonds with internal solvent and Tyr-70, Glu-51, and Ser-71. In the apoprotein, the side chain of Lys-27 spans this potential opening, closing off the core to the surface, while in the holoprotein the side chain of Lys-27 is in a position that allows access ofexterior solvent 0 to the core. As discussed below, these side chains may affect solvent movement to and from the interior of I-FABP.
The Fatty Acid Binding Site Is Occupied by Ordered Solvent
Molecules in Apo-I-FABP. The refined 2.0-A structure of I-FABP with bound palmitate indicated that a single molecule of fatty acid was present in the interior of the /8-clam (7) . Its carboxylate group is buried deep in the protein, while the bent hydrocarbon tail extends toward the portal parallel, and in close proximity, to strands /1D and /3E (Fig. 1) . The carboxylate group was hydrogen bonded to the guanidinium group of Arg-106 via an electrostatic network containing at least three other polar groups: the side-chain oxygen of Asn-115 and two ordered solvent molecules. The core of I-FABP with bound palmitate also contains seven ordered solvent molecules. These solvent molecules are distributed along the length ofthe concave face ofthe bent fatty acid, close to the "gap" between /3strands D and E.
The of 0.78 A. Of these, only Ala-73 shows any significant mainchain movement (rms = 1.5 A). Moreover, most of the conformational dissimilarity is restricted to the side chains of Ile-23, Lys-27, Leu-72, Ala-73, and Asp-74. The rms difference for the side chains of these residues is 1.4 A. The side chains of Ile-23, Leu-72, and Ala-73 are oriented in the direction of the bound fatty acid in holo-I-FABP. In the apoprotein, they are directed toward other hydrophobic regions. For example, in the holoprotein, the 6-carbon of Ile-23 is pointing toward, and is within van der Waals radius of, the C16 atom of the bound palmitate. However, in the refined structure ofthe apoprotein, the C8 of Ile-23 is turned away and points toward the interior of the protein (Fig. 3 Upper) .
While the side chains of residues which appear to provide critical interactions with the bound ligand are comparably positioned within the cores ofthe apo-and holoproteins (e.g., note the superimpositions of Tyr-70, Arg-106,-ard Gln-115 in Fig. 3 Lower), significant differences were noted in numbers and locations of ordered solvent molecules. The interior of the apoprotein contains 13 ordered solvent molecules; 6 are located in positions which are occupied by comparable solvent molecules in the holoprotein, while additional solvent molecules are present at locations which are close to those occupied by the C1, C2, C8, and C15 atoms of palmitate ( Figs. 1 and 3 ). An ordered solvent molecule replaces the carboxylate group of palmitate, permitting the apoprotein to retain the five-membered hydrogen bonding network analogous to that present in the holoprotein. Thus, in the apoprotein, this complex consists of three, rather than two, ordered solvent molecules as well as the side-chain oxygen ofGln-115 and the 8 guanidinium group of Arg-106. There is no continuity of electron density in either the 21FOI -IFJI map or the IFOI -IFCI map of apo-I-FABP which could be construed as bound fatty acid. Moreover, the refined temperature factors of the ordered solvent atoms in this area are consistent with the idea that they represent ordered solvent and are not density from other molecules such as buffer ions. Furthermore, a significant volume of the core of apo-I-FABP is not occupied by ordered atoms.
Proposed Mechanism of Fatty Acid Binding. In the highresolution study of holo-I-FABP (7), we proposed that the entry of palmitate into the interior of the protein may be facilitated by a series of charge interactions occurring between its carboxylate group and a number of polar side chains. Binding of the carboxylate group to the side chain of a basic amino acid located on the surface of the protein would be followed by ligand entry through the portal area and subsequent incorporation of the carboxylate into the fivemembered hydrogen bonding network. In this scheme, the conformation assumed by the hydrocarbon tail would be dictated by the hydrophobic binding pocket formed by the side chains of nonpolar and aromatic amino acids, although it was not clear to what extent the ligand affected the location of these side chains. This pathway would allow the protein to incorporate the fatty acid without distorting its native conformation (i.e., by breaking many hydrogen bonds or moving a number of hydrophobic side chains). Our analysis of the structure of apo-I-FABP is consistent with this type of mechanism. Specifically, it now appears that the final conformational state of crystalline apo-I-FABP is remarkably similar to that of the protein with bound ligand. This suggests that the 3-clam structure is not dependent upon the presence of bound fatty acid. Moreover, the data indicate that ligand removal is associated with little alteration in the orientation of side chains in the portions of the binding pocket which Proc. Natl. Acad. Sci. USA 86 (1989) interact with either its carboxylate group or its hydrocarbon tail. At least two observations suggest that ordered solvent molecules may play a role in the process of ligand acquisition and removal: (i) six "extra" ordered solvent molecules occupy the protein core in areas previously populated by ligand, and (ii) some of the most "dramatic" differences in the side chain orientations of apo-and holo-protein can be mapped to those residues which overlie a potential opening to their cores. One testable hypothesis arising from these structural studies is that acquisition and release of fatty acids by I-FABP is intimately related to a subtle low-energy process predicated on solvent movement. Moreover, such movement may be affected in part by the mobile side chains of Arg-56 and/or Lys-27. In this scheme, the presence of more ordered solvent molecules in the interior of the apoprotein compared to the holoprotein could be an entropic factor which favors fatty acid binding. Additional higher resolution studies of apo-and holo-I-FABP are needed to better define the nature and interactions of ordered solvent. Site-directed mutagenesis of I-FABP and subsequent expression ofgenetically engineered protein(s) in E. coli should also provide a way of directly examining the hypothesis that alterations in solvent movement play an important role in the binding mechanism.
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